Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;13(11):e007264.
doi: 10.1161/CIRCOUTCOMES.120.007264. Epub 2020 Nov 12.

Cardio-Renal-Metabolic Care Models: Toward Achieving Effective Interdisciplinary Care

Affiliations

Cardio-Renal-Metabolic Care Models: Toward Achieving Effective Interdisciplinary Care

Janani Rangaswami et al. Circ Cardiovasc Qual Outcomes. 2020 Nov.
No abstract available

Keywords: cardiology; diabetes, type 2; kidney; nephrology; workflow.

PubMed Disclaimer

Figures

Figure.
Figure.
Components of a successful cardio-renal-metabolic care model at an institutional level. A successful multidisciplinary model would include physician or advanced practice provider, dietician, clinical pharmacist, care navigator, and administrative representative from all 3 specialties sharing the care of patients at high risk/with established cardio-renal-metabolic disease. Such a program would be based on mutually common decision-making algorithms across all 3 specialties, shared documentation platforms, frequent interface of the care team members (virtually or in-person), and periodic review of clinical outcomes, adverse events, patient experience, and program financial viability. Such a model would also incorporate patient and caregiver representation to align interventions with patient-centered values and therapeutic goals. DKD indicates diabetic kidney disease.

References

    1. Bright R. Cases and observations illustrative of renal disease accompanied by the secretion of albuminous urine. Guys Hospital Rep. 1836;338.
    1. Bhatt AS, Vaduganathan M, Butler J. Growing mismatch between evidence generation and implementation in heart failure. Am J Med. 2020;133:525–527. doi: 10.1016/j.amjmed.2019.11.032 - PubMed
    1. McCoy RG, Dykhoff HJ, Sangaralingham L, Ross JS, Karaca-Mandic P, Montori VM, Shah ND. Adoption of new glucose-lowering medications in the U.S.-The Case of SGLT2 inhibitors: Nationwide Cohort Study. Diabetes Technol Ther. 2019;21:702–712. doi: 10.1089/dia.2019.0213 - PMC - PubMed
    1. Patel RB, Al Rifai M, McEvoy JW, Vaduganathan M. Implications of specialist density for diabetes care in the United States. JAMA Cardiol. 2019;4:1174–1175. doi: 10.1001/jamacardio.2019.3796 - PMC - PubMed
    1. Beddhu S, Shen J, Cheung AK, Kimmel PL, Chertow GM, Wei G, Boucher RE, Chonchol M, Arman F, Campbell RC, Contreras G, Dwyer JP, Freedman BI, Ix JH, Kirchner K, Papademetriou V, Pisoni R, Rocco MV, Whelton PK, Greene T. Implications of early decline in eGFR due to intensive BP control for cardiovascular outcomes in SPRINT. J Am Soc Nephrol. 2019;30:1523–1533. doi: 10.1681/ASN.2018121261 - PMC - PubMed

MeSH terms